We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-13.62%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$261B
AUM Growth
-$56.5B
Cap. Flow
-$9.3B
Cap. Flow %
-3.56%
Top 10 Hldgs %
16.51%
Holding
3,995
New
135
Increased
1,816
Reduced
1,720
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 18.75%
2 Financials 13.28%
3 Healthcare 12.15%
4 Consumer Discretionary 11.49%
5 Communication Services 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
3626
CALL
Emerson Electric
EMR
$81.6B
$36K ﹤0.01%
+600
New +$40.5K
GASS icon
3627
StealthGas
GASS
$326M
$36K ﹤0.01%
13,219
-2,206
-14% -$7.39K
MCD icon
3628
CALL
McDonald's
MCD
$193B
$36K ﹤0.01%
+200
New +$35.5K
MDT icon
3629
CALL
Medtronic
MDT
$112B
$36K ﹤0.01%
+400
New +$37.4K
KA
3630
DELISTED
Kineta, Inc. Common Stock
KA
$36K ﹤0.01%
+79
New +$53.5K
MRNS
3631
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$35K ﹤0.01%
3,014
-1,376
-31% -$27.8K
CLDX icon
3632
Celldex Therapeutics
CLDX
$2.94B
$34K ﹤0.01%
11,545
+1,217
+12% +$5.98K
HRL icon
3633
CALL
Hormel Foods
HRL
$14.2B
$34K ﹤0.01%
+800
New +$34.5K
SPGI icon
3634
CALL
S&P Global
SPGI
$124B
$34K ﹤0.01%
+200
New +$35.8K
PVLA
3635
Palvella Therapeutics
PVLA
$2.05B
$34K ﹤0.01%
160
+1
+0.6% +$310
ENZ
3636
DELISTED
Enzo Biochem, Inc.
ENZ
$32K ﹤0.01%
11,348
+95
+0.8% +$311
CLX icon
3637
CALL
Clorox
CLX
$12B
$31K ﹤0.01%
+200
New +$31.2K
GD icon
3638
CALL
General Dynamics
GD
$103B
$31K ﹤0.01%
+200
New +$35.8K
LCTX icon
3639
Lineage Cell Therapeutics
LCTX
$264M
$31K ﹤0.01%
33,796
-4,491
-12% -$6.88K
LIN icon
3640
CALL
Linde
LIN
$236B
$31K ﹤0.01%
+200
New +$31.6K
RTW
3641
DELISTED
RTW Retailwinds, Inc.
RTW
$31K ﹤0.01%
+10,933
New +$33.6K
TLRA
3642
DELISTED
Telaria, Inc.
TLRA
$31K ﹤0.01%
11,493
+1,175
+11% +$3.4K
ECL icon
3643
CALL
Ecolab
ECL
$79.8B
$29K ﹤0.01%
+200
New +$30.5K
LEE icon
3644
Lee Enterprises
LEE
$175M
$29K ﹤0.01%
1,383
-50
-3% -$1.24K
VFC icon
3645
CALL
VF Corp
VFC
$5.92B
$29K ﹤0.01%
+425
New +$32.5K
MBII
3646
DELISTED
Marrone Bio Innovations, Inc.
MBII
$28K ﹤0.01%
19,047
-17,798
-48% -$27.3K
ASCMA
3647
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$28K ﹤0.01%
72,715
+8,569
+13% +$8.32K
WBA
3648
CALL
DELISTED
Walgreens Boots Alliance
WBA
$27K ﹤0.01%
+400
New +$31K
ADP icon
3649
CALL
Automatic Data Processing
ADP
$109B
$26K ﹤0.01%
+200
New +$28.2K
JNJ icon
3650
CALL
Johnson & Johnson
JNJ
$640B
$26K ﹤0.01%
+200
New +$27.9K

Similar funds

Invesco's Q4 2018 Portfolio in Review

As of Q4 2018, Invesco held 3,995 positions worth $261B, down 18% from $318B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Invesco withdrew a net $9.3B in Q4 2018, closing 180 positions and reducing 1,720 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $691M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Invesco opened a new position in Linde worth $106M.

  • Invesco's largest Q4 2018 buy was Linde: 679,076 shares worth $106M.
  • Invesco added most to NXP Semiconductors in Q4 2018, an estimated $253M increase.
  • Invesco's biggest Q4 2018 reduction was Apple, cutting an estimated $961M.
  • Invesco fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $691M.
  • Invesco's ten largest holdings make up 17% of its $261B portfolio in Q4 2018.
  • Invesco opened 135 new positions and closed 180 in Q4 2018.
  • Invesco's portfolio value fell 18% quarter-over-quarter to $261B.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.